Current progress on aptamer-targeted oligonucleotide therapeutics

Author： Dassie Justin P   Giangrande Paloma H  

Publisher： Future Science

ISSN： 2041-5990

Source： Therapeutic Delivery, Vol.4, Iss.12, 2013-12, pp. : 1527-1546

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aptamer-Targeted Oligonucleotide Theranostics: A Smarter Approach for Brain Delivery and the Treatment of Neurological Diseases

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 12, 2015-06 ,pp. : 1115-1124

Bentham Science Publishers

Access to resources Recommend Favorite

Recent progress in oligonucleotide therapeutics: antisense to aptamers

By Leaman Douglas W  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 9, 2008-09 ,pp. : 997-1009

Informa Healthcare

Access to resources Recommend Favorite

Target Acquired: Progress and Promise of Targeted Therapeutics in the Treatment of Prostate Cancer

By  

Current Cancer Drug Targets, Vol. 15, Iss. 5, 2015-01 ,pp. : 394-405

Bentham Science Publishers

Access to resources Recommend Favorite

Antisense oligonucleotide therapeutics

By Bennett C.F.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 3, 1999-03 ,pp. : 255-255

Informa Healthcare

Access to resources Recommend Favorite

Antisense Anticancer Oligonucleotide Therapeutics

By  

Current Cancer Drug Targets, Vol. 1, Iss. 3, 2001-01 ,pp. : 177-196

Bentham Science Publishers

Access to resources Recommend Favorite